Paradigm Biopharmaceuticals Ltd (PAR)

Currency in AUD
0.34
0.00(0.00%)
Closed·
PAR Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
PAR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.340.36
52 wk Range
0.170.66
Key Statistics
Bid/Ask
0.35 / 0.32
Prev. Close
0.35
Open
0.35
Day's Range
0.34-0.36
52 wk Range
0.17-0.66
Volume
719.86K
Average Volume (3m)
854.77K
1-Year Change
40%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PAR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.88
Upside
+158.82%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Paradigm Biopharmaceuticals Ltd Company Profile

Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. It lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is headquartered in Melbourne, Australia.

Compare PAR to Peers and Sector

Metrics to compare
PAR
Peers
Sector
Relationship
P/E Ratio
−9.6x−6.0x−0.5x
PEG Ratio
−0.11−0.050.00
Price/Book
4.1x3.0x2.6x
Price / LTM Sales
8,329.4x14.0x3.3x
Upside (Analyst Target)
151.4%269.8%43.5%
Fair Value Upside
Unlock10.0%6.3%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 0.88
(+158.82% Upside)

Earnings

Latest Release
Feb 27, 2025
EPS / Forecast
-0.02 / --
Revenue / Forecast
16.70K / --
EPS Revisions
Last 90 days

PAR Income Statement

FAQ

What Stock Exchange Does Paradigm Biopharmaceuticals Ltd Trade On?

Paradigm Biopharmaceuticals Ltd is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Paradigm Biopharmaceuticals Ltd?

The stock symbol for Paradigm Biopharmaceuticals Ltd is "PAR."

What Is the Paradigm Biopharmaceuticals Ltd Market Cap?

As of today, Paradigm Biopharmaceuticals Ltd market cap is 135.13M.

What Is Paradigm Biopharmaceuticals Ltd's Earnings Per Share (TTM)?

The Paradigm Biopharmaceuticals Ltd EPS (TTM) is -0.05.

From a Technical Analysis Perspective, Is PAR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Paradigm Biopharmaceuticals Ltd Stock Split?

Paradigm Biopharmaceuticals Ltd has split 2 times.

How Many Employees Does Paradigm Biopharmaceuticals Ltd Have?

Paradigm Biopharmaceuticals Ltd has 0 employees.

What is the current trading status of Paradigm Biopharmaceuticals Ltd (PAR)?

As of 05 Aug 2025, Paradigm Biopharmaceuticals Ltd (PAR) is trading at a price of 0.34, with a previous close of 0.35. The stock has fluctuated within a day range of 0.34 to 0.36, while its 52-week range spans from 0.17 to 0.66.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.